“…Quantitative proteomics aims to measure relative and absolute proteome changes across various experimental conditions to expand understanding of disease, mechanistic pathways, and biological processes . Enhanced multiplexing technologies such as N -hydroxysuccinimide-ester tandem labeling in one pot (NETLOP), 29-plex tandem mass tag (TMT), TAG-TMTpro, combined precursor isotopic labeling and isobaric tagging (cPILOT), and others − enable high-throughput proteomics experiments by combining more than one multiplexing technology into a single experiment. For example, NETLOP combines isotopic and isobaric versions of TMT tags to achieve up to 48-plex labeling, TAG-TMTpro combines amino acid labeling with TMT isobaric tags to achieve up to 45-plex labeling, and cPILOT combines isotopic dimethylation and TMT or dimethyl leucine (DiLeu) isobaric tags to achieve up to 42-plex labeling. − ,,, cPILOT can encompass multiple conditions such as tissue types, time points, and genotypes and has been broadly applied to study aging, Alzheimer’s disease, ,, and post-translational modifications .…”